According to a recent LinkedIn post from Acclaro Medical, the company is preparing a major presence at the American Society for Laser Medicine and Surgery, Inc. 2026 meeting in Savannah. The post highlights live “Fiber Focus” sessions featuring the UltraClear 2910 nm fiber laser, with demonstrations, before-and-after results, and clinical discussions at booth 126.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Acclaro Medical is targeting a broad range of high-demand dermatologic and aesthetic indications, including scarring, skin of color, periorbital rejuvenation, nasal contouring, and combination treatments. Multiple named physicians and industry experts are promoted as speakers, which may help drive peer adoption and clinical validation among laser-medicine specialists.
From an investor perspective, this type of conference activity points to ongoing commercialization efforts around the UltraClear platform and could support lead generation, practitioner engagement, and procedure-volume growth. If the technology resonates with clinicians at ASLMS 2026, Acclaro Medical may strengthen its competitive positioning in the energy-based aesthetic device market and expand its installed base and recurring revenue opportunities.